| dbo:abstract
|
- غوردون ويشارت (بالإنجليزية: Gordon Wishart) هو جراح بريطاني، ولد في 3 سبتمبر 1960. (ar)
- Professor Gordon C Wishart FRCS (Eng.) FRCS (Gen.) (3 September 1960-) is the founder, Chief Medical Officer, and CEO of Check4Cancer, an early cancer detection and prevention company. In 2016, Check4Cancer launched rapid access, streamlined, and audited diagnostic pathways for breast and skin cancer to the insured and self-pay markets, leading to the award of “Diagnostic Provider of the Year” at the annual Health Investor Awards in 2018. In late 2017, Check4Cancer launched the first worldwide breast cancer risk test (MyBreastRisk) to combine genetic, family history, and lifestyle risk factors to underpin a risk-stratified breast screening programme. As the former Director of the Cambridge Breast Unit from 2005-2010, and current Professor of Cancer Surgery at Anglia Ruskin School of Medicine since 2008, he has contributed in clinical research and modernisation of cancer diagnosis and treatment, with more than 100 peer-reviewed papers in scientific journals. In 2010, he led a team of clinicians and scientists that developed the PREDICT breast cancer treatment and survival model, which is now used worldwide. (en)
|
| dbo:academicDiscipline
| |
| dbo:almaMater
| |
| dbo:birthDate
| |
| dbo:birthPlace
| |
| dbo:knownFor
| |
| dbo:nationality
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 11161 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:almaMater
| |
| dbp:birthDate
| |
| dbp:birthPlace
| |
| dbp:field
| |
| dbp:knownFor
|
- Diagnosis and treatment of breast cancer, development of Predict cancer survival model, founder of Check4Cancer Ltd (en)
|
| dbp:name
|
- Professor Gordon C Wishart (en)
|
| dbp:nationality
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workInstitution
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- غوردون ويشارت (بالإنجليزية: Gordon Wishart) هو جراح بريطاني، ولد في 3 سبتمبر 1960. (ar)
- Professor Gordon C Wishart FRCS (Eng.) FRCS (Gen.) (3 September 1960-) is the founder, Chief Medical Officer, and CEO of Check4Cancer, an early cancer detection and prevention company. In 2016, Check4Cancer launched rapid access, streamlined, and audited diagnostic pathways for breast and skin cancer to the insured and self-pay markets, leading to the award of “Diagnostic Provider of the Year” at the annual Health Investor Awards in 2018. In late 2017, Check4Cancer launched the first worldwide breast cancer risk test (MyBreastRisk) to combine genetic, family history, and lifestyle risk factors to underpin a risk-stratified breast screening programme. (en)
|
| rdfs:label
|
- غوردون ويشارت (ar)
- Gordon Wishart (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Professor Gordon C Wishart (en)
|
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is dbp:name
of | |
| is foaf:primaryTopic
of | |
